ResearcherChung Shan Medical University HospitalActive in the last 2 years
Wen‐Wei Sung
Matched on ORCID iD 0000-0002-2375-0029; OpenAlex author ID A5003548884. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- The Therapeutic Role of NPS-1034 in Pancreatic Ductal Adenocarcinoma as Monotherapy and in Combination with Chemotherapy. Co-author DOI 10.3390/ijms25136919↗
- PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic Cancer. Co-author DOI 10.3390/medicina59091531↗
- Symptomatic cholelithiasis patients have an increased risk of pancreatic cancer: A population-based study. Co-author DOI 10.1111/jgh.15234↗
- Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries. Last author DOI 10.1136/bmjopen-2017-020618↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ming‐Chang Tsai · 4 shared papers, 2018–2024 · strength 0.64
- Paper The Therapeutic Role of NPS-1034 in Pancreatic Ductal Adenocarcinoma as Monotherapy and in Combination with Chemotherap… DOI 10.3390/ijms25136919↗
- Paper PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic Cancer. DOI 10.3390/medicina59091531↗
- Paper Symptomatic cholelithiasis patients have an increased risk of pancreatic cancer: A population-based study. DOI 10.1111/jgh.15234↗
- Chi‐Chih Wang · 4 shared papers, 2018–2024 · strength 0.64
- Paper The Therapeutic Role of NPS-1034 in Pancreatic Ductal Adenocarcinoma as Monotherapy and in Combination with Chemotherap… DOI 10.3390/ijms25136919↗
- Paper PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic Cancer. DOI 10.3390/medicina59091531↗
- Paper Symptomatic cholelithiasis patients have an increased risk of pancreatic cancer: A population-based study. DOI 10.1111/jgh.15234↗
- Hsiang‐Lin Lee · 2 shared papers, 2018–2023 · strength 0.26
- Yu‐Ze Luan · 1 shared paper, 2024 · strength 0.26
- Tai-Long Chien · 1 shared paper, 2023 · strength 0.18
- Hsueh‐Chou Lai · 1 shared paper, 2021 · strength 0.12
- Cheng‐Ming Peng · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.